Show 1362: Lowdown on New Medicines for Treating Obesity –Part 2

The People's Pharmacy

Joe and Terry Graedon

Health & Fitness, Medicine, Kids & Family, Alternative Health

4.5 • 934 Ratings

🗓️ 2 November 2023

⏱️ 59 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week’s radio show is the second of a two-part series on new medicines for treating obesity. This episode features Dr. Robert Lustig, neuroendocrinologist and anti-obesity crusader. He discusses the uses and disadvantages of drugs such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro). In addition, he offers a completely different way to combat obesity. You […]

Transcript

Click on a timestamp to play from that location

0:00.0	I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.
0:06.1	You can find previous podcasts and more information on a range of health topics at
0:11.5	People's Pharm pharmacy.com.
0:14.0	Americans love easy solutions to complex problems.
0:18.0	Maybe that's why weight loss drugs like Wegovi are so popular.
0:22.0	This is the People's Pharmacy with Terry and Joe Grady. GLP1 agonists like Ozimpic, Monjaro and Wigovi help people lose more weight than previous
0:41.0	medications.
0:42.0	Are there downsides?
0:44.0	Today, part two of our two-part series about the benefits and risks of medications like
0:50.0	we govy. We've invited two medical experts to share their different
0:54.2	perspectives on strategies to overcome obesity. Today's guest is author of
0:59.0	metabolic allure and the lies of processed food, nutrition, and modern medicine.
1:04.4	Coming up on the People's Pharmacy, a different view on medicines for obesity.
1:20.3	In the Peebles Pharmacy Health Headlines, COVID-19 infections can give rise to a wide range of conditions that persist long after the original infection is gone.
1:24.6	Researchers wondered if using the antiviral medicine Paxilovid
1:28.8	during the acute phase of COVID would reduce the likelihood of post COVID conditions.
1:34.9	To find out, they compared the health records of patients treated for COVID at the Veterans
1:39.5	Health Administration in 2022. More than 9,500 were treated with Pax Lovett. Their subsequent health problems
1:48.2	were compared to those who did not receive Pax Lovet, though they were similar in other ways.
1:54.5	The investigators were disappointed to find that Paxilovit reduced the chance of only one
1:59.3	type of complication, blood clots in the legs or in the lungs. Other post-Covid problems did not
2:06.2	respond. The FDA recently issued a warning about contaminated eye drops. Inspectors found unsanitary conditions at a
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.